A new paper showing that soft gel or liquid T4 better controls T4 dose in patients with central hypothyroidism - accessible paper.
l-Thyroxine in an Oral Liquid or Softgel Formulation Ensures More Normal Serum Levels of Free T4 in Patients with Central Hypothyroidism
Salvatore Benvenga, Giovanni Capodicasa and Sarah Perelli
Original Research Context: L-thyroxine therapy of central hypothyroidism (CH) is guided by measurements of serum free thyroxine (FT4), which should be above the midnormal range value (MNRV). In some countries, novel formulations of oral L-thyroxine (liquid or softgel) ...
Published on 20 November 2017
Front. Endocrinol. doi: 10.3389/fendo.2017.00321